David Vroman to Prospective Studies
This is a "connection" page, showing publications David Vroman has written about Prospective Studies.
Connection Strength
0.058
-
Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification: prospective randomized double-masked study. J Cataract Refract Surg. 2002 Jan; 28(1):93-9.
Score: 0.029
-
Randomized, double-masked clinical trial evaluating corneal endothelial cell loss after cataract extraction and intraocular lens implantation: Fluid-based system versus ultrasound phacoemulsification. Cornea. 2006 Oct; 25(9):1043-5.
Score: 0.010
-
Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation. J Ocul Pharmacol Ther. 2006 Aug; 22(4):251-7.
Score: 0.010
-
Flap thickness accuracy: comparison of 6 microkeratome models. J Cataract Refract Surg. 2004 May; 30(5):964-77.
Score: 0.009